使用CRISPR/Cas9在人类诱导的多能干细胞衍生巨细胞中,证据表明TNFRSF1A在内1中的增强剂活性
Julie A Osgood1, Andrew C Brown1,2, Katie L Burnham1
1Centre for Human Genetics, University of Oxford, Oxford, UK.
Scientific reports
|October 7, 2025
概括
研究人员使用CRISPR基因编辑研究了巨细胞中瘤坏死因子受体超级家族成员1A (TNFRSF1A) 的调节. 他们发现了一种内部增强元件,进步了对免疫介导疾病的遗传变异的理解.
科学领域:
- 遗传学 是一个遗传学.
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
背景情况:
- 瘤坏死因子α (TNFα) 是一种关键的炎症调解剂和自身免疫性疾病的药物标.
- 它的受体TNFRSF1A在遗传上与免疫介导的疾病,如缩性脊髓炎和多发性硬化症有关.
- 在TNFRSF1A附近的遗传变异,通常在非编码区域,复杂的疾病协会的理解.
研究的目的:
- 研究巨细胞中TNFRSF1A的基因调节,巨细胞是免疫系统中关键的细胞类型.
- 为了功能性地表征与免疫介导疾病相关的非编码遗传变异.
- 为了确定TNFRSF1A基因位点内的调节元素.
主要方法:
- 在人类诱导多能干细胞 (hiPSCs) 中利用了CRISPR/Cas9基因编辑.
- 分化编辑的hiPSCs转化为细胞环境中的巨细胞.
- 使用功能性基因组学技术:ATAC-Seq,ChIP-Seq和RNA-Seq来评估基因调节.
主要成果:
- 确定了一个功能增强元件,位于TNFRSF1A基因的内部.
- 通过基因组读数证明了基因编辑对TNFRSF1A调控元素的影响.
- 提供了关于特定调节区域在控制TNFRSF1A表达中的作用的证据.
结论:
- 这项研究阐明了巨细胞中TNFRSF1A基因调节,这对于了解免疫媒介疾病至关重要.
- 发现了一种影响TNFRSF1A表达的内基增强剂,为GWAS变体功能提供了洞察力.
- 这项研究有助于解开常见疾病的遗传基础,并确定新的治疗点.
关键词:
克里斯普尔是什么意思?克里斯普尔是什么意思?表观基因组学是指表观基因组学.功能性基因组学是一种功能性基因组学.基因调节 基因调节这就是TNFRSF1A.文字转录学 (Transcriptomics) 是一个学科.更多相关视频
相关概念视频
CRISPR
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced Short...
Homologous Recombination
The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
CRISPR/Cas9 Genome Editing
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...


